AS
Altshuler Shaham Portfolio holdings
AUM
$3.14B
1-Year Return
24.55%
This Quarter Return
+29.46%
1 Year Return
+24.55%
3 Year Return
+51.84%
5 Year Return
+71.45%
10 Year Return
–
AUM
$3.32B
AUM Growth
+$1.18B
(+55%)
Cap. Flow
+$662M
Cap. Flow
% of AUM
19.95%
Top 10 Holdings %
Top 10 Hldgs %
78.4%
Holding
631
New
95
Increased
142
Reduced
57
Closed
309
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$395M |
| 2 |
Alibaba
BABA
|
$300M |
| 3 |
TSMC
TSM
|
$215M |
| 4 |
Blackrock
BLK
|
$196M |
| 5 |
Cisco
CSCO
|
$123M |
Top Sells
| 1 |
Financial Select Sector SPDR Fund
XLF
|
$333M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$154M |
| 3 |
Elbit Systems
ESLT
|
$97.5M |
| 4 |
WIX.com
WIX
|
$65.7M |
| 5 |
Mastercard
MA
|
$2.62M |
Sector Composition
| 1 | Technology | 27.68% |
| 2 | Financials | 23.58% |
| 3 | Consumer Discretionary | 16.02% |
| 4 | Healthcare | 3.25% |
| 5 | Industrials | 2.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Veeva Systems
VEEV
$44.7B
| $64K | ﹤0.01% |
273
+269
| +6,725% | +$63.1K |
|
177
Insulet
PODD
$24.5B
| $63K | ﹤0.01% |
325
+114
| +54% | +$22.1K |
|
178
Tandem Diabetes Care
TNDM
$850M
| $63K | ﹤0.01% |
+635
| New | +$63K |
|
179
Zynex
ZYXI
$45.1M
| $63K | ﹤0.01% |
+2,779
| New | +$63K |
|
180
Idexx Laboratories
IDXX
$51.4B
| $60K | ﹤0.01% |
182
+128
| +237% | +$42.2K |
|
181
AbbVie
ABBV
$375B
| $59K | ﹤0.01% |
603
+183
| +44% | +$17.9K |
|
182
Accenture
ACN
$159B
| $59K | ﹤0.01% |
273
+141
| +107% | +$30.5K |
|
183
Halozyme
HALO
$8.76B
| $57K | ﹤0.01% |
+2,112
| New | +$57K |
|
184
Neurocrine Biosciences
NBIX
$14.3B
| $57K | ﹤0.01% |
+467
| New | +$57K |
|
185
Mettler-Toledo International
MTD
$26.9B
| $54K | ﹤0.01% |
67
+48
| +253% | +$38.7K |
|
186
Spotify
SPOT
$146B
| $53K | ﹤0.01% |
+204
| New | +$53K |
|
187
Autodesk
ADSK
$69.5B
| $52K | ﹤0.01% |
219
+57
| +35% | +$13.5K |
|
188
Exelixis
EXEL
$10.2B
| $52K | ﹤0.01% |
2,174
+2,143
| +6,913% | +$51.3K |
|
|
LMNX
189
DELISTED
Luminex Corp
LMNX
| $52K | ﹤0.01% |
+1,590
| New | +$52K |
|
190
United Therapeutics
UTHR
$18.1B
| $49K | ﹤0.01% |
401
+101
| +34% | +$12.3K |
|
191
AtriCure
ATRC
$1.76B
| $47K | ﹤0.01% |
1,038
+240
| +30% | +$10.9K |
|
|
AVLR
192
DELISTED
Avalara, Inc.
AVLR
| $47K | ﹤0.01% |
355
+307
| +640% | +$40.6K |
|
193
iRhythm Technologies
IRTC
$5.82B
| $46K | ﹤0.01% |
+398
| New | +$46K |
|
194
MSCI
MSCI
$42.9B
| $46K | ﹤0.01% |
138
+40
| +41% | +$13.3K |
|
195
DocuSign
DOCU
$16.1B
| $45K | ﹤0.01% |
264
-18
| -6% | -$3.07K |
|
196
Factset
FDS
$14B
| $45K | ﹤0.01% |
138
+68
| +97% | +$22.2K |
|
197
Jack Henry & Associates
JKHY
$11.8B
| $45K | ﹤0.01% |
242
+72
| +42% | +$13.4K |
|
198
Equinix
EQIX
$75.7B
| $44K | ﹤0.01% |
+62
| New | +$44K |
|
199
Pegasystems
PEGA
$9.5B
| $43K | ﹤0.01% |
856
+480
| +128% | +$24.1K |
|
200
S&P Global
SPGI
$164B
| $43K | ﹤0.01% |
131
+28
| +27% | +$9.19K |
|